New external scientific members join the MPIMG
The MPIMG is excited that Claudia Langenberg and Malte Spielmann joined the institute as external scientific members of the Max Planck Society this year. These positions are held by outstanding researchers with close ties to an MPI, who help strengthen the institute’s scientific network and foster collaborations. They began their work at the institute with a mini symposium in March.
Claudia Langenberg’s lab focuses on integrating genetic, biological, and multi-omics data from large-scale population and clinical studies to characterize the genetic architecture of human metabolism and its impact on health and disease. Her work has been instrumental in translating these data into mechanistic insights across a range of diseases. She is currently Director of the Precision Healthcare University Research Institute at Queen Mary University of London and Honorary Consultant Physician in Public Health at the Department of Health and Social Care, England. In addition, she holds a professorship in Computational Medicine in Berlin, further strengthening our ties to the Berlin Institute of Health (BIH) at Charité. “I am extremely excited to become part of the environment that the MPIMG and its outstanding scientists offer. I hope to build bridges between molecular, clinical and population sciences to help translate genomic insights into human health”, she comments.
Read more about Claudia Langenberg’s work:
http://www.omicscience.org
https://www.linkedin.com/company/phuri/
https://www.bihealth.org/en/research/research-group/computational-medicine
Malte Spielmann has made pioneering contributions to elucidating the role of non-coding and structural variants in human disease. His research has provided fundamental insights into how mutations exert pleiotropic effects during embryogenesis and how they influence the 3D architecture of the genome. By leveraging cutting-edge high-throughput technologies, particularly in the context of mouse embryonic development, his laboratory has advanced our understanding of gene regulation in development and disease. Since January 2026 he is the director of the Institute of Medical and Human Genetics at Charité, continuing our collaboration with the largest Hospital in Berlin. Malte relocated to Berlin from Northern Germany, where he previously served as director of the Institutes of Human Genetics at the University Medical Center Schleswig-Holstein (UKSH) at the Kiel and Lübeck campuses. “Understanding the genome requires more than reading its sequence—it demands decoding the regulatory language that shapes human development and disease. There is no better place than the MPIMG to do this, and I am truly thrilled and honored to be part of such an exceptional team,” says Malte.
Read more about Malte Spielmann’s work:
